We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00283179
Recruitment Status : Completed
First Posted : January 27, 2006
Last Update Posted : May 15, 2008
Information provided by:
Taiwan Otsuka Pharm. Co., Ltd